Consulier Engineering, Inc.
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
     
þ   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2008
     
o   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
COMMISSION FILE NUMBER 0-17756
CONSULIER ENGINEERING, INC.
 
(Exact name of small business issuer as specified in its charter)
     
Florida   59-2556878
     
(State or other jurisdiction of
of incorporation or organization)
  (I.R.S. Employer Identification No.)
2391 Old Dixie Highway
Riviera Beach, FL 33404
 
(Address of principal executive offices)
(561) 842-2492
 
(Registrant’s telephone number, including area code)
 
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x     No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
 
Large accelerated filer o   Accelerated filer o   Non-accelerated filer o   Smaller reporting company x
      (Do not check if a smaller reporting company)  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 126-2 of the Exchange Act).
Yes o     No x
 
 

 


Table of Contents

APPLICABLE ONLY TO CORPORATE ISSUERS
Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date:
As of May 1, 2008, there were 5,304,524 outstanding shares of common stock, par value $0.01 per share.

2


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Report on Form 10Q contains “forward-looking statements” within the meanings of the Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements include statements preceded by, followed by or that include the words “may,” “could,” “would,” “should,” “believe,” “expect,” “anticipate,” “plan,” “estimate,” “target,” “project,” “intend,” or similar expressions. The statements include, among others, statements regarding our prospects, opportunities, outlook, plans, intentions, anticipated financial and operating results, our business strategy and means to implement the strategy, and objectives.
Forward-looking statements are only estimates or predictions and are not guarantees of performance. These statements are based on our management’s beliefs and assumptions, which in turn are based on currently available information. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products and services, competition from existing and new competitors, our ability to introduce new products, expected pricing levels, the timing and cost of planned capital expenditures, competitive conditions and general economic conditions. These assumptions could prove inaccurate. Forward-looking statements also involve risks and uncertainties, which could cause actual results to differ materially from those contained in any forward-looking statement. Among other things, continued unfavorable economic conditions may impact market growth trends or otherwise impact the demand for our products and services; competition from existing and new competitors and producers of alternative products will impact our ability to penetrate or expand our presence in new or growing markets. Uncertainties relating to our ability to develop and distribute new proprietary products to respond to market needs in a timely manner may impact our ability to exploit new or growing markets; our ability to successfully identify and implement productivity improvements and cost reduction initiatives may impact profitability.
In addition, unless otherwise specifically provided herein, the statements in this Report are made as of end of the period for which the Report is filed. We expect that subsequent events or developments will cause our views to change. We undertake no obligation to update any of the forward-looking statements made herein, whether as a result of new information, future events, changes in expectations or otherwise. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the end of the period for which the Report is filed.

3


 

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
INDEX
                 
            Page  
               
 
               
               
 
               
            5  
 
               
            6  
 
               
            7  
 
               
            8  
 
               
            9  
 
               
            28  
 
               
            31  
 
               
            31  
 
               
               
 
               
            33  
 
               
            33  
 
               
            34  
 
               
            35  
 
               
            35  
 
               
            35  
 
               
            35  
 
               
            36  
 
               
CERTIFICATIONS
             
 EX-31.1 Section 302 Certification of CEO
 EX-31.2 Section 302 Certification of CFO
 EX-32.1 Section 906 Certification of CEO
 EX-32.2 Section 906 Certification of CFO

4


Table of Contents

PART-I. FINANCIAL INFORMATION
Item 1. Financial Statements
CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
                 
    March 31,     December 31,  
    2008     2007  
    (UNAUDITED)          
ASSETS
               
 
               
CURRENT ASSETS
               
Cash and Cash Equivalents
  $ 497,443     $ 333,024  
Receivables, Net of Allowance for Doubtful Accounts of $0
    1,078,294       927,574  
Inventories
    41,125       40,987  
Deferred Implementation Costs
    1,968,818       2,024,785  
Other Current Assets
    120,186       89,663  
Deferred Income Taxes
    291,208       291,208  
 
           
 
               
Total Current Assets
    3,997,074       3,707,241  
 
               
PROPERTY AND EQUIPMENT, Net
    1,400,014       1,473,287  
CAPITALIZED SOFTWARE DEVELOPMENT COSTS
    178,194       215,204  
PARTNERSHIP AND LIMITED LIABILITY COMPANIES — INVESTMENTS
    2,902,441       3,091,930  
DEFERRED INCOME TAXES
    570,170       541,988  
INTANGIBLE ASSET
    721,873       847,339  
OTHER ASSETS
    30,693       30,693  
 
           
 
               
 
  $ 9,800,459     $ 9,907,682  
 
           
 
               
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
 
               
CURRENT LIABILITIES
               
Accounts Payable and Accrued Liabilities
  $ 1,219,910     $ 1,340,484  
Unearned Revenue
    806,101       822,659  
Related Party Payable
    858,783       773,646  
Income Tax Payable
    88,277       79,932  
 
           
Total Current Liabilities
    2,973,071       3,016,721  
 
           
 
               
NOTES PAYABLE — RELATED PARTY
    3,405,062       3,405,062  
 
           
 
               
COMMITMENTS AND CONTINGENCIES
               
 
               
MINORITY INTEREST
    284,680       232,000  
 
           
 
               
STOCKHOLDERS’ EQUITY:
               
Common Stock $.01 Par Value:
               
Authorized 25,000,000 Shares; Issued 5,485,122 Shares
    54,851       54,851  
Additional Paid-in Capital
    4,117,221       4,117,221  
Accumulated Deficit
    (473,459 )     (461,135 )
 
           
 
    3,698,613       3,710,937  
 
               
Less:
               
Treasury Stock, Cost - 180,598 and 145,262 Shares, respectively
    (554,316 )     (427,891 )
Notes Receivable for Common Stock
    (6,651 )     (29,147 )
 
             
 
               
Total Stockholders’ Equity
    3,137,646       3,253,899  
 
           
 
               
 
  $ 9,800,459     $ 9,907,682  
 
           
The Accompanying Notes are an Integral
Part of These Consolidated Financial Statements

5


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
                 
    THREE MONTHS ENDED  
    MARCH 31,  
    2008     2007  
Revenue:
               
Software Licensing Fees
  $ 885,155     $ 367,361  
Other Revenue
    3,717       4,003  
 
           
Total Revenue
    888,872       371,364  
 
           
 
               
Operating Costs and Expenses:
               
Cost of Revenue
    251,325       121,935  
Payroll and Related Expense
    853,780       1,084,764  
Selling, General and Administrative
    586,099       699,958  
Professional Services
    373,827       418,292  
Depreciation and Amortization
    279,852       251,766  
 
           
 
               
Total Operating Costs and Expenses
    2,344,883       2,576,715  
 
           
 
               
Operating Loss
    (1,456,011 )     (2,205,351 )
 
           
 
               
Other Income (Expense):
               
Investment Income — Related Parties
    1,166,049       628,807  
Net Undistributed Income (Loss) of Equity Investees
    (43,813 )     94,276  
Interest Expense
    (83,564 )     (97,593 )
Other Income
    62,868       41,698  
 
           
 
               
Total Other Income (Expense)
    1,101,540       667,188  
 
           
 
               
(Loss) from Operations Before Minority Interest and Income Taxes
    (354,471 )     (1,538,163 )
 
               
Minority Interest in Consolidated Subsidiary Losses
    313,984       2,137,006  
 
           
 
               
Income (Loss) from Operations Before Income Taxes
    (40,487 )     598,843  
 
               
Benefit (Provision) for Income Taxes
    28,163       (223,323 )
 
           
Net Income (Loss)
  $ (12,324 )   $ 375,520  
 
           
 
               
Income (Loss) Per Share — Basic and Diluted:
  $ (0.00 )   $ 0.07  
 
           
The Accompanying Notes are an Integral
Part of These Consolidated Financial Statements

6


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
THREE MONTHS ENDED MARCH 31, 2008
(UNAUDITED)
                                                                 
                                                    Notes        
                                                    Receivable        
                                    Additional             for     Total  
    Common Stock     Treasury Stock     Paid-in     (Accumulated     Common     Stockholders’  
    Shares     Amount     Shares     Amount     Capital     Deficit)     Stock     Equity  
Balance, December 31, 2007
    5,485,122     $ 54,851       145,262     $ (427,891 )   $ 4,117,221     $ (461,135 )   $ (29,147 )   $ 3,253,899  
 
                                                               
Net Loss
                                  (12,324 )           (12,324 )
 
                                                               
Purchase of Treasury Stock
                35,336       (126,425 )                       (126,425 )
 
                                                               
Collection of Notes Receivable for Common Stock
                                        22,496       22,496  
 
                                                               
 
                                               
Balance, March 31, 2008
    5,485,122     $ 54,851       180,598     $ (554,316 )   $ 4,117,221     $ (473,459 )   $ (6,651 )   $ 3,137,646  
 
                                               
The Accompanying Notes are an Integral
Part of These Consolidated Financial Statements

7


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
                 
    THREE MONTHS ENDED  
    MARCH 31,  
    2008     2007  
Cash Flow (Used in) Operating Activities
  $ (1,536,777 )   $ (2,187,325 )
 
           
 
               
Investing Activities:
               
 
               
Distributions from Partnership Interest
    1,389,091       628,807  
Acquisition of Property and Equipment
    (23,703 )     (29,515 )
Acquisition of Software Upgrades
    (20,400 )     (44,100 )
 
           
 
               
Net Cash Provided by Investing Activities
    1,344,988       555,192  
 
           
 
               
Financing Activities:
               
Proceeds from Minority Shareholder in ST, LLC
    375,000       2,243,393  
Increase in Related Party Payables
    85,137       81,040  
Proceeds from Subscription Receivable
    22,496        
Purchase of Treasury Stock
    (126,425 )      
Repayments on Line of Credit
          (575,000 )
 
           
 
               
Net Cash Provided by Financing Activities
    356,208       1,749,433  
 
           
 
               
Increase in Cash and Cash Equivalents
    164,419       117,300  
 
               
Cash and Cash Equivalents — Beginning of Period
    333,024       241,428  
 
           
 
               
Cash and Cash Equivalents — End of Period
  $ 497,443     $ 358,728  
 
           
 
               
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
               
Cash Paid for Interest
  $     $ 13,973  
 
           
The Accompanying Notes are an Integral
Part of These Consolidated Financial Statements

8


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of Business
Consulier Engineering, Inc., and its subsidiaries (collectively called “Consulier” or the “Company”) are engaged in three primary business lines: ownership in medical software activities, distribution of Captain Cra-Z Soap™ and minority ownership of other business entities.
Consulier International, Inc. (a subsidiary) markets and distributes Captain Cra-Z Soap™ .
Consulier’s income is also derived from ownership of interests (Note 4) in BioSafe Systems, LLC (“BioSafe”), and AVM, L.P. (“AVM”), an Illinois limited partnership. BioSafe develops and markets environmentally safe products, alternatives to traditionally toxic pesticides. AVM is a broker-dealer in government securities and other fixed income instruments. Consulier’s Chairman and majority stockholder, Warren B. Mosler (“Mosler”), is a general partner of the general partner of AVM.
ST, LLC, a majority-owned (51%) limited liability company, is a majority member (75%) of Patient Care Technology Systems, LLC (“PCTS”), which develops and licenses data-based integrated emergency room information systems marketed as Amelior ED™. PCTS is also a provider of passive tracking technologies for emergency departments and operating rooms. Its software technologies track the status and location of patients and assets through wireless badges worn by people or attached to equipment in the emergency department and ancillary areas. PCTS also designs, customizes, markets, sells and distributes paper templates used for diagnostic purposes in emergency medical departments. Mosler’s ownership in ST, LLC was approximately 24% as the Class A member and Consulier’s ownership was approximately 51% as of March 31, 2008.
Basis of Consolidation
The accompanying condensed interim consolidated financial statements include Consulier and its wholly-owned subsidiary, Consulier International, Inc., and ST, LLC, with its majority- owned subsidiary, PCTS. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company uses the equity method of accounting for investments where its ownership is between 20% and 50% (Note 4).

9


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Interim Financial Data
The accompanying unaudited condensed interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. However, management believes the accompanying unaudited condensed interim consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary to present fairly the consolidated financial position of Consulier Engineering, Inc. and subsidiaries as of March 31, 2008, and the results of their operations and cash flows for the three months ended March 31, 2008. The results of operations and cash flows for the period are not necessarily indicative of the results of operations or cash flows that can be expected for the year ending December 31, 2008. For further information, refer to the consolidated financial statements and footnotes thereto included in Consulier’s annual report on Form 10-KSB for the year ended December 31, 2007.
Accounting Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are used when accounting for allowances for doubtful accounts, software and service revenue, revenue reserves, inventory reserves, depreciation and amortization, taxes, contingencies and impairment allowances, if any. Such estimates are reviewed on an ongoing basis. Actual results could differ from these estimates and those differences may be material.

10


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Concentrations
Financial instruments, which potentially expose the Company to concentrations of credit risk, as defined by Statement of Financial Accounting Standards No. 105, Disclosure of Information about Financial Instruments with Off-Balance-Sheet Risk and Financial Instruments with Concentrations of Credit Risk, consist primarily of accounts receivable. ST, LLC’s accounts receivable are concentrated in the healthcare industry. Although, ST, LLC’s customers typically have been well-established hospitals or medical facilities, some hospitals and medical facilities have experienced significant operating losses as a result of limits on third-party reimbursements from insurance companies and governmental entities, and extended payment of receivables from these entities is not uncommon.
To date, PCTS has relied on a limited number of customers for a substantial portion of its total revenues. The Company expects that a significant portion of its future revenues will continue to be generated by a limited number of customers. The failure to obtain new customers or expand sales through remarketing partners, the loss of existing customers, or the reduction in revenues from existing customers could materially and adversely affect the Company’s operating results.
PCTS currently buys all of its hardware and some major software components of its emergency room information systems from third-party and related-party vendors (Note 10). Although there are a limited number of vendors capable of supplying these components, management believes that other suppliers could provide similar components on comparable terms. A change in suppliers, however, could cause a delay in system implementations and a possible loss of revenues, which could adversely affect operating results
Capitalized Software Development Costs
Software development costs are accounted for in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 86, Accounting for the Costs of Software to be Sold, Leased or Otherwise Marketed. Costs associated with the planning and designing phase of software development, including coding and testing activities necessary to establish technological feasibility, are classified as product research and development and are expensed as incurred. Once technological feasibility has been determined, a portion of the costs incurred in development, including coding, testing, and product quality assurance, are capitalized and subsequently reported at the lower of unamortized cost or net realizable value.

11


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Capitalized Software Development Costs (Continued)
Amortization is provided on a product-by-product basis over the estimated economic life of the software, not to exceed three years, using the straight-line method. Amortization commences when a product is available for general release to customers. Unamortized capitalized costs determined to be in excess of the net realizable value of a product are expensed at the date of such determination. Amortization expense on capitalized software development costs totaled $57,410 and $26,833 for the three months ended March 31, 2008 and 2007, respectively. Accumulated amortization totaled $1,218,627 and 1,161,217 at March 31, 2008 and December 31, 2007, respectively.
The Company required third party expertise for the development of a new data-based integrated emergency room information system to enhance the functionality, reliability and flexibility of the Company’s existing products, which has not achieved the criteria for capitalization. For the three months ended March 31, 2008 and 2007, research and development costs totaled $188,288 and $356,787, respectively. These expenses are included with professional services in the accompanying condensed interim consolidated statements of operations.
Partnership and Limited Liability Company Investments
The Company’s interest in AVM and Biosafe constitute less than 50% of the ownership of each entity and are accordingly accounted for using the equity method. The Company owns in excess of 50% of ST, LLC, thereby requiring consolidation. The Company owns less than 8% in AVM; however, the Company has the ability to significantly influence this investee under the terms of the partnership agreement. Income or loss is allocated to Consulier based on the partnership and LLC agreements of AVM, BioSafe and ST, LLC. The Company reviews its interest in each of these companies for other than temporary declines in value on a monthly basis by analyzing actual revenue, earnings capacity and estimated future undiscounted cash flows.

12


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Partnership and Limited Liability Company Investments (Continued)
Effective April 1, 2005, the operating agreement of ST, LLC was amended to reallocate membership interests in this LLC based upon historical contributions. The Company receives allocated losses to the extent of its contributions from inception. Consequently, the losses allocated to Consulier can be greater than or less than the Company’s ownership percentage.
As a result of consolidating ST, LLC, a minority interest was created representing the other member. As of March 31, 2008 there was $52,680 related to this minority interest available to offset future losses.
Effective April 1, 2006, ST, LLC’s operating agreement was amended to create a Class A membership interest. The Class A members are entitled to a cumulative annual priority return of 10% on their investment, and cash available for distribution after payment of that return is distributable to all of the members in accordance with their percentage membership interests. In accordance with this amendment to the operating agreement, allocations of losses are based upon historical annual contributions. As of March 31, 2008, the Class A member had invested $13,197,571, which included an investment of $375,000 during the three months ended March 31, 2008. Unpaid cumulative priority returns on the Class A membership interest totaled approximately $1,817,000 and $1,492,000 at March 31, 2008 and December 31, 2007, respectively.
Consulier can require its principal stockholder to purchase its interest in ST, LLC for cash equal to Consulier’s capital account as of the closing date. Consulier has contributed to ST, LLC approximately $17,017,000 million since inception. As of March 31, 2008, Consulier’s capital account was $0.
Stock-Based Compensation
On January 1, 2006, the Company adopted the fair value recognition provisions of Financial Accounting Standards Board (“FASB”) Statement No. 123(R), Share-Based Payment, (“SFAS 123(R)”). Prior to January 1, 2006, the Company accounted for share-based payments under the recognition and measurement provisions of APB Opinion No. 25, Accounting for Stock Issued to Employees (“APB25”), and related Interpretations, as permitted by FASB Statement No. 123, “Accounting for Stock-Based Compensation (“SFAS 123”). In accordance with APB 25, no compensation cost was required to be recognized for options granted that had an exercise price equal to the market value of the underlying common stock on the date of grant.

13


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Stock-Based Compensation (Continued)
The Company adopted SFAS 123(R) using the modified-prospective-transition method. Under this method, compensation cost recognized includes: a) compensation cost for all share-based payments granted prior to, but not yet vested as of December 31, 2005, based on the grant-date fair value estimated in accordance with the original provisions of SFAS 123, and b) compensation cost for all share-based payments granted subsequent to December 31, 2005, based on the grant-date fair value estimated in accordance with the provisions of SFAS 123(R). In addition, deferred stock compensation related to non-vested options is required to be eliminated against additional paid-in capital upon adoption of SFAS 123(R).
During the three months ended March 31, 2008, there were no stock options granted to employees.
Revenue Recognition
The Company derives revenue from the following sources: (1) licensing and sale of data- based integrated emergency room information systems and passive tracking technologies, which include new software license and software license updates and product support revenues and (2) services, which include consulting, advanced product services and education revenues. The following generally describes the revenue accounting followed by the Company.
New software license revenues represent all fees earned from granting customers licenses to use the Company’s database and tracking technology as well as applications software, and exclude revenue derived from software license updates, which is included in software license updates and product support. While the basis for software license revenue recognition is substantially governed by the provisions of Statement of Position (“SOP”) No. 97-2, Software Revenue Recognition, issued by the American Institute of Certified Public Accountants, the Company exercises judgment and uses estimates in connection with the determination of the amount of software and services revenues to be recognized in each accounting period.

14


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Revenue Recognition (Continued)
For software license arrangements that do not require significant modification or customization of the underlying software, the Company recognizes new software license revenue when: (1) the Company enters into a legally binding arrangement with a customer for the license of software; (2) the Company delivers the products; (3) a customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is probable. Substantially all new software license revenues are recognized in this manner. The vast majority of software license arrangements include software license updates and product support, which are recognized ratably over the term of the arrangement, typically one year. Software license updates provide customers with rights to unspecified software product upgrades, maintenance releases and patches released during the term of the support period. Product support includes internet access to technical content, as well as internet and telephone access to technical support personnel. Software license updates and product support are generally priced as a percentage of the net new software license fees.
Many of PCTS’s software arrangements include consulting implementation services sold separately under consulting engagement contracts. Consulting revenue from these arrangements is generally accounted for separately from new software license revenue because the arrangements qualify as service transactions as defined in SOP No. 97-2. The more significant factors considered in determining whether the revenue should be accounted for separately include the nature of services (i.e. consideration of whether the services are essential to the functionality of the licensed product), degree of risk, availability of services from other vendors, timing of payments and impact of milestones or acceptance criteria on the realizability of the software license fee.
Revenue for consulting services is generally recognized as the services are performed. If there is a significant uncertainty about the project completion or receipt of payment for the consulting services, revenue is deferred until the uncertainty is sufficiently resolved. Contracts with fixed or “not to exceed” fees are recognized on a proportional performance basis.
If an arrangement does not qualify for separate accounting of the software license and consulting transactions, then new software license revenue is generally recognized together with the consulting services based on contract accounting using either the percentage-of-completion or completed-contract method. Contract accounting is applied to any arrangements: (1) that include milestones or customer specific acceptance criteria that may affect collection of the software license fees; (2) where services include significant modification or customization of the software; (3) where significant consulting services are provided for in the software license contract without additional charge or are substantially discounted; or (4) where the software license payment is tied to the performance of consulting services.

15


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Revenue Recognition (Continued)
Advanced product services revenue is recognized over the term of the service contract, which is generally one year. Education revenue is recognized as the classes or other education offerings are delivered.
For arrangements with multiple elements, the Company allocates revenue to each element of a transaction based upon its fair value as determined by “vendor specific objective evidence.” Vendor specific objective evidence of fair value for all elements of an arrangement is based upon the normal pricing and discounting practices for those products and services when sold separately, and for software license updates and product support services, is additionally measured by the renewal rate offered to the customer.
The Company defers revenue for any undelivered elements, and recognizes revenue when the product is delivered or over the period in which the service is performed, in accordance with the revenue recognition policy for such element. If the Company cannot objectively determine the fair value of any undelivered element included in bundle software and service arrangements, the Company defers revenue until all elements are delivered and services have been performed, or until fair value can objectively be determined for any remaining undelivered elements. When the fair value of a delivered element has not been established, the residual method is used to record revenue if the fair value of all undelivered elements is determinable. Under the residual method, the fair value of the undelivered elements is deferred and the remaining portion of the arrangement fee is allocated to the delivered elements and is recognized as revenue.
Sales of the Company’s soap products are recorded upon shipment of goods to customers.
Shipping and handling costs billed to customers are included in sales and recorded when goods are shipped to customers. Shipping costs of the Company are classified as a selling expense.
Advertising and Marketing Costs
Advertising costs are expensed as incurred and amounted to approximately $79,000 and $82,000 for the three months ended March 31, 2008 and 2007, respectively.
Income Taxes
The Company accounts for income taxes under the liability method. Under this method, deferred tax liabilities and assets are determined based on the difference between the consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.

16


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Income Taxes (Continued)
As part of the process of preparing our consolidated financial statements, the Company is required to estimate its income taxes in each of the jurisdictions in which it operates. This process involves estimating current tax exposure together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included within the Company’s consolidated balance sheet. The Company then assesses the likelihood that the deferred tax assets will be recovered from future taxable income and to the extent it believes that recovery is not likely, it establishes a valuation allowance. To the extent the Company establishes a valuation allowance or changes this allowance in a period, it includes an expense or a benefit within the tax provision in the Company’s statement of operations.
In June 2006, the Financial Accounting Standards Board published FASB Interpretation No. 48 (FIN no. 48). “Accounting for Uncertainty in Income Taxes,” to address the non-comparability in reporting tax assets and liabilities resulting from a lack of specific guidance in FASB Statement of Financial Accounting Standards No. 109 (SFAS 109), “Accounting for Income Taxes,” on the uncertainty in income taxes recognized in an enterprise’s financial statements. Specifically, FIN No. 48 prescribes (a) a consistent recognition threshold and (b) a measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return, and provides related guidance on derecognition, classification, interest and penalties, accounting interim periods, disclosure and transition. FIN 48 requires companies to determine whether it is “more likely than not” that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the financial statements. For those tax positions where it is “not more likely than not” that a tax benefit will be sustained, no tax benefit is recognized. Where applicable associated interest and penalties are also recorded. FIN No. 48 applies to fiscal years beginning after December 15, 2006, with earlier adoption permitted.
The Company adopted the provisions of FIN 48 on January 1, 2007. As a result of the implementation of FIN 48, the Company had no changes in the carrying value of its tax assets or liabilities for any unrecognized tax benefits.

17


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Newly Issued Accounting Pronouncements
In September 2006, the FASB issued SFAS 157, “Fair Value Measurements” (SFAS 157”). SFAS 157 defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles, and expands disclosures about fair value measurements. For all of our financial assets and liabilities that are recognized and disclosed at fair value on a recurring basis, we adopted the provisions of SFAS 157 effective January 1, 2008. The implementation of SFAS No. 157 did not have a material effect on the Company’s consolidated financial statements. For all assets and liabilities that are non-financial that are recognized or disclosed at fair value in the financial statements on a non-recurring basis we plan to adopt the provisions of SFAS 157 effective January 1, 2009. This partial deferral was a result of Staff Position 157-2 “Effective Date of FASB Statement No. 157” (FSP 157-2”) issued on February 12, 2008, which delayed the adoption of SFAS 157 for non-financial assets and liabilities that are recognized or disclosed at fair value on a non-recurring basis. We are currently evaluating the impact of SFAS 157-2 on our financial statements relative to non-financial assets and liabilities.
On February 15, 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities (SFAS No. 159). Under SFAS No. 159, the Company may elect to report financial instruments and certain other items at fair value on a contract-by-contract basis with changes in value reported in earnings. This election is irrevocable. SFAS No. 159 provides an opportunity to mitigate volatility in reported earnings that is caused by measuring hedged assets and liabilities that were previously required to use a different accounting method than the related hedging contracts when the complex provisions of SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities, applicable to hedge accounting are not met. The Company adopted SFAS No. 159 on January 1, 2008. The Company chose not to elect the fair value option for its financial assets and liabilities existing at January 1, 2008 and did not elect the fair value option on financial assets and liabilities transacted in the three months ended March 31, 2008. Therefore, the adoption of SFAS No. 159 had no impact on the Company’s interim condensed consolidated financial statements.

18


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Newly Issued Accounting Pronouncements (Continued)
In March 2008, the FASB issued SFAS 161 “Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133” (SFAF 161”), which is effective for fiscal years and interim periods beginning after November 15, 2008, with earlier adoption encourages. This statement is intended to improve transparency in financial reporting by requiring enhanced disclosures of an entity’s derivative instruments and hedging activities and their effects on the entity’s financial position, financial performance, and cash flows. SFAS 161 applies to all derivative instruments within the scope of SFAS 133, “Accounting for Derivative Instruments and Hedging Activities” (“SFAS 133”) as well as related hedged items, bifurcated derivatives, and non-derivative instruments that are designated and qualify as hedging instruments. We do not expect SFAS 161 to have a material impact on our consolidated financial statements and plan to adopt it effective January 1, 2009.
In December 2007, the FASB issued SFAS 141R “Business Combinations” (“SFAS 141R”), which is effective prospectively for all business combinations with acquisition dates on or after the beginning of the first fiscal year beginning after December 15, 2008, with the exception of the accounting for valuation allowances on deferred taxes and acquired tax contingencies. SFAS 141R replaces SFAS 141 “Business Combinations” (“SFAS 141”), but it retains the underlying concepts of SFAS 141 in that all business combinations are required to be accounted for at fair value under the acquisition method of accounting. However, SFAS 141R changed the method of applying the acquisition method in a number of significant ways. Acquisition costs will generally be expensed as incurred; noncontrolling interest will be valued at fair value at the acquisition date; in-process research and development will be recorded at fair value at the acquisition date as an indefinite-lived intangible asset; restructuring cost associated with a business combination will generally be expensed subsequent to the acquisition date; and changes in deferred tax asset valuation allowances and income tax uncertainties after the acquisition date generally will affect income tax expense. We do not expect SFAS 141R to have a material impact on our consolidated financial statements and plan to adopt it effective January 1, 2009.

19


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Newly Issued Accounting Pronouncements (Continued)
In December 2007, the FASB issued SFAS 160 “Non-controlling Interests in Consolidated Financial Statements” (“SFAS160”), which amends Accounting Research Bulletin (“ARB”) 51, “Consolidated Financial Statements” (“ARB 51”). SFAS 160 is effective for quarterly and annual reporting periods that begin after December 15, 2008. SFAS 160 establishes accounting and reporting standards with respect to non-controlling interests (also called minority interests) in an effort to improve the relevance, comparability and transparency of financial information that a company provides with respect to its non-controlling interests. The significant requirements under SFAS 160 are the reporting of the non-controlling interests separately in the equity section of the balance sheet and the reporting of the net income or loss of the controlling and non-controlling interests separately on the face of the statement of operations. We do not expect SFAS 160 to have a material impact on our consolidated financial statements and plan to adopt it effective January 1, 2009.
NOTE 2. DEFERRED IMPLEMENTION COSTS
Deferred implementation costs as of March 31, 2008 and December 31, 2007, totaled $1,968,818 and $2,024,785, respectively, and represented equipment purchased for customers, payroll and payroll related expenses for customer contracts which have not met certain milestones, customer acceptance or “go-live” dates. Implementation costs are deferred and recognized ratably over the initial licensing term or upon reaching certain milestones, acceptance criteria or “go-live” dates depending on the applicable revenue stream. Deferred implementation costs are stated at the lower of cost or market.
NOTE 3. CONCENTRATION OF CREDIT RISK
The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents. The Company places its cash with high credit quality financial institutions. Cash held by these financial institutions in excess of FDIC limits amounted to approximately $368,000 at March 31, 2008.
The Company grants credit to customers, substantially all of whom are businesses located in the United States and Canada. The Company typically does not require collateral from customers. The Company monitors exposure to credit losses and maintains allowances for anticipated losses considered necessary in the circumstances.

20


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 3. CONCENTRATION OF CREDIT RISK (CONTINUED)
Approximately 43% of the Company’s software licensing fees were derived from two customers for the three months ended March 31, 2008. Customer A and B represented approximately 31% and 12%, respectively, of total software licensing fees for the three months ended March 31, 2008. Approximately 20% of the Company’s software licensing fees were derived from one customer for the three months ended March 31, 2007.
NOTE 4. INVESTMENTS — PARTNERSHIP AND LIMITED LIABILITY COMPANY
The Company’s limited partnership and limited liability company interests consist of Consulier’s investments in AVM, L.P. and BioSafe Systems, LLC, respectively.
AVM, L.P.
Consulier owned an approximate 7.5% limited partnership interest in AVM as of March 31, 2008 and 2007. Based on capital and earnings distributions provided in the partnership agreement, Consulier was allocated approximately 5.6% of AVM’s earnings during the three months ended March 31, 2008 and 2007. Under the partnership agreement, Consulier may withdraw all or any portion of its capital account upon 30 days written notice.
The following is a summary of the results of operations (unaudited) of AVM and the income allocated to the Company:
                 
    Three Months Ended  
    March 31,  
    (In Thousands)  
    (Unaudited)  
    2008     2007  
Revenues
  $ 43,413     $ 22,914  
Cost and Expenses
    22,727       11,520  
 
           
Net Income
  $ 20,686     $ 11,394  
 
           
 
               
Consulier’s Share of Earnings
  $ 1,166     $ 629  
 
           
The carrying value of the Company’s investment in AVM, L.P. at March 31, 2008 and December 31, 2007 was $1,852,133 and $1,997,810, respectively.

21


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 4. INVESTMENTS — PARTNERSHIP AND LIMITED LIABILITY COMPANY (CONTINUED)
BIOSAFE SYSTEMS, LLC
Consulier owns a 40% interest in BioSafe Systems, LLC (“BioSafe”). The following is a summary of the results of operations of BioSafe and the income allocated to Consulier:
                 
    Three Months Ended  
    March 31,  
    (In Thousands)  
    (Unaudited)  
    2008     2007  
Revenues
  $ 1,786     $ 1,689  
Cost and Expenses
    1,896       1,453  
 
           
Net Income (Loss)
  $ (110 )   $ 236  
 
           
 
               
Consulier’s Share of Earnings (Loss)
  $ (44 )   $ 94  
 
           
The carrying value of Consulier’s investment in BioSafe was $1,050,307 and $1,094,120 at March 31, 2008 and December 31, 2007, respectively.
NOTE 5. TREASURY STOCK
During the three months ended, March 31, 2008, the Company repurchased 35,336 shares of its common stock for $126,425, representing the market value of the Company’s common shares on the date of purchase plus broker commissions.
NOTE 6. EARNINGS PER SHARE
Basic earnings per share is calculated by dividing net income (loss) available to stockholders by the weighted average number of common shares outstanding during each period. Diluted earnings per share is computed using the weighted average number of common and dilutive potential common shares outstanding during the period. Dilutive potential common shares consist of shares issuable upon the exercise of stock awards (calculated using the treasury stock method) warrants, convertible debt and convertible preferred stock during the period they were outstanding.

22


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 6. EARNINGS PER SHARE (CONTINUED)
Basic and diluted earnings per share for the three months ended March 31, 2008 and 2007 were calculated as follows:
                 
    Three Months Ended  
    March 31,  
    2008     2007  
BASIC AND DILUTED INCOME (LOSS) PER SHARE COMPUTATION:
               
 
               
NUMERATOR:
               
Net Income (Loss)
  $ (12,324 )   $ 375,520  
 
           
 
               
DENOMINATOR:
               
Average number of common shares outstanding
    5,320,823       5,485,122  
 
           
 
               
 
  $ (.00 )   $ .07  
 
           
As of March 31, 2008 and 2007, the Company did not have any dilutive outstanding common stock instruments to be included in its diluted earnings per share computation.
NOTE 7. SEGMENT INFORMATION
Operating segments are components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company has four reportable segments: distribution of household and tool products, ownership of limited liability entities, medical software activities, and corporate. The household and tool products manufacturing segment is engaged in sales of the Captain Cra-Z soap product line and tool and ladder related products. The investments segment maintains investment interests in a limited partnership and a limited liability company (which are together called “Limited Liability Companies” in the following tables). The corporate segment is engaged in management of the business and finance activities.

23


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 7. SEGMENT INFORMATION (CONTINUED)
Segment information as of and for the three months ended March 31, 2008 and 2007 are as follows:
                                         
    Three Months Ended March 31, 2008  
            Income (Loss)                      
            Derived From                      
            Ownership of             Medical        
    Distribution     Limited Liability     Corporate     Software        
    Activities     Companies     Activities     Activities     Total  
Revenue (b)
  $ 3,717     $     $     $ 885,155     $ 888,872  
Operating (Loss)
    (33,706 )           (204,274 )     (1,218,031 )     (1,456,011 )
Other Income (Loss)
          1,122,236       64,491       (85,187 )     1,101,540  
Minority Interest
                      313,984       313,984  
Income Tax Benefit (Provision)
    11,096       (401,756 )     51,720       367,103       28,163  
Net Income (Loss) (a)
    (22,610 )     720,480       (88,063 )     (622,131 )     (12,324 )
Total Assets
  $ 50,272     $ 2,902,441     $ 2,602,286     $ 4,245,460     $ 9,800,459  
                                         
    Three Months Ended March 31, 2007  
            Income (Loss)                      
            Derived From                      
            Ownership of             Medical        
    Distribution     Limited Liability     Corporate     Software        
    Activities     Companies     Activities     Activities     Total  
Revenue (b)
  $ 4,003     $     $     $ 367,361     $ 371,364  
Operating (Loss)
    (22,763 )           (139,040 )     (2,043,548 )     (2,205,351 )
Other Income (Loss)
          723,083       37,563       (93,458 )     667,188  
Minority Interest
                      2,137,006       2,137,006  
Income Tax Benefit
    7,967       (277,597 )     46,307             (223,323 )
(Provision)
                                       
Net Income (Loss) (a)
    (14,796 )     445,486       (55,170 )           375,520  
Total Assets
  $ 65,781     $ 2,805,280     $ 3,132,583     $ 4,813,913     $ 10,817,557  
 
(a)   All interest expense incurred by the Company was allocated to the Corporate Activities Segment.
 
(b)   There was no intersegment revenue during the period.

24


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 8. INCOME TAXES
Provisions (benefit) for federal and state income tax in the interim condensed consolidated statements of operations consist of the following:
                 
    For the Three Months  
    Ended March 31,  
    2008     2007  
Current:
               
Federal
  $     $  
State
           
 
           
 
           
 
           
 
               
Deferred:
               
Federal
    (25,477 )     201,780  
State
    (2,686 )     21,543  
 
           
 
    (28,163 )     223,323  
 
           
 
               
Total income tax provision (benefit)
  $ (28,163 )   $ 223,323  
 
           
Applicable income taxes (benefit) for financial reporting purposes differ from the amount computed by applying the statutory federal income tax rate as follows:
                 
    Three Months Ended  
    March 31,  
    2008     2007  
Federal tax expense (benefit) at statutory rate
  $ (120,520 )   $ 196,216  
State income tax expense (benefit) net of federal tax effect
    (12,867 )     21,738  
Losses allocated to minority shareholder of ST, LLC
    103,072        
Meals and Entertainment
    2,152        
Other
          5,369  
 
           
 
               
Income tax expense (benefit)
  $ (28,163 )   $ 223,323  
 
           
As of March 31, 2008, the Company had Federal and state tax loss carry-forwards totaling approximately $40,000 and $6,500,000, respectively, available to reduce future years’ income through 2024.

25


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 8. INCOME TAXES (CONTINUED)
The approximate tax effects of temporary differences that give rise to deferred tax assets (liabilities) as of March 31, 2008 are as follows:
         
Depreciation and Amortization
  $ 287,137  
Tax loss carry forward
    250,996  
Accrued Interest — Note Payable, Related Party
    323,245  
 
     
 
       
Total Net Deferred Tax Asset
  $ 861,378  
 
     
Deferred tax assets and liabilities are reflected on the balance sheet as of March 31, 2008 as follows:
         
Net Short-Term Deferred Tax Assets
  $ 291,208  
Net Long-Term Deferred Tax Assets
    570,170  
 
     
 
       
Net Deferred Tax Assets
  $ 861,378  
 
     
NOTE 9: COMMITMENTS AND CONTINGENCIES
From time to time, the Company is involved in lawsuits and claims in the ordinary course of business. Management does not believe the outcome of any litigation against the Company would have a material adverse effect on the Company’s financial position or results of operations.
On August 2, 2006, PCTS was made a defendant to a lawsuit filed by Hill-Rom Services, Inc. et al. vs. Versus Technology, et al., United States District Court, Middle District of North Carolina, Civil Action No. 1:03CV01227, as a successor in interest to Healthcare Information Technology, Inc., and as a customer of a vendor concerning the vendor’s disputed patent ownership and unauthorized use of such patents. Effective January 21, 2008, all claims against PCTS were settled and the cased was dismissed.

26


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO THE UNAUDITED CONDENSED INTERIM CONSOLIDATED
FINANCIAL STATEMENTS
NOTE 10. RELATED PARTY TRANSACTIONS
NOTE PAYABLE — RELATED PARTY
ST, LLC has unsecured promissory notes to the majority stockholder totaling $3,405,062 as of March 31, 2008, the proceeds of which have been used to meet operating funding requirements. These promissory notes accrue interest at 10% per annum, compounding monthly. Interest only is payable annually on the anniversary date of each of the promissory notes. The promissory notes and any accrued interest are due on demand anytime after 10 years from the applicable date of the note. Accordingly, the total unpaid principal balance is included in long-term liabilities on the accompanying condensed interim consolidated balance sheet. The Company may not prepay the principal balance without prior consent of the majority stockholder. Accrued interest on this note totaled $858,783 and $773,646 and is included in related party payable on the accompanying consolidated balance sheets as of March 31, 2008 and December 31, 2007, respectively.
OTHER RELATED PARTY TRANSACTIONS
PCTS’s president is also the majority owner of a company that provides materials related to the Company’s passive tracking technologies. The Company paid this vendor approximately $82,000 through May 2008 for these materials. Amounts due this related party vendor totaled $42,992 and $77,992 as of March 31, 2008 and December 31, 2007, respectively. These amounts are included in accounts payable and accrued expenses on the accompanying condensed consolidated balance sheets.

27


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
RESULTS OF OPERATIONS
Gross revenue, which is predominantly software licensing fees, was approximately 139% greater in the first quarter ended March 31, 2008, compared to the quarter ended March 31, 2007 due to the completion of implementation projects at certain hospitals.
The operating loss for the three months ended March 31, 2008, was approximately $1,456,000 compared to an operating loss for the three months ended March 31, 2007, of $2,205,000. This reduction in operating loss of approximately $749,000 was largely due to a reduction in operating expenses and professional services, as it relates to software changes in PCTS’ primary software solutions, which were nearing completion.
During the quarter ended March 31, 2008, other income (expense) increased by approximately $434,000, primarily driven by the Company’s interest in AVM Ltd., whose income was approximately 85% greater than for the same period of 2007. However, the results of operations from the Company’s interest in BioSafe Systems was approximately $44,000 loss in the first quarter of 2008 compared to income of $94,276 for the quarter ended March 31, 2007. The negative results were due to cost increases in raw materials and freight. BioSafe implemented a price increase in March of 2008 in an attempt to offset these additional cost.

28


Table of Contents

LIQUIDITY AND CAPITAL RESOURCES
The Company’s cash position increased $164,419 in the three months ended March 31, 2008, compared to an increase of $117,300 during the comparable period in 2007. Net cash flow used in operations for the three months ended March 31, 2008, was approximately $1.5 million dollars, compared with cash used in operations of approximately $2.2 million dollars for the three months ended March 31, 2007. The primary reason for the $700,000 difference is a decrease in operating costs and the recognition of deferred revenues associated with completed implementation contracts.
Net cash provided by financing activities was approximately $356,000 for the three months ended March 31, 2008, compared to cash provided by financing activities of approximately $1,749,000 for the three months ended March 31, 2007. Net cash provided by financing activities in both periods were primarily affected from proceeds from the minority shareholder amounting to approximately $375,000 and $2,243,000 for the quarters ended March 31, 2008 and 2007, respectively. Cash provided by financing activities was offset by the repayment of the line-of-credit totaling $575,000 during the three months ended March 31, 2007.
Net cash provided by investing activities relates primarily to the distribution from AVM of approximately $1,389,000 for the three months ended March 31, 2008, which was offset by the continued acquisition of software upgrades in the PCTS subsidiary. This compares to net cash provided by investing activities for the three months ended March 31, 2007 of $555,192. The distribution from AVM for that quarter was $628,807.
The ability of Consulier to continue to generate cash flow in excess of its normal operating requirements depends almost entirely on the performance of its limited partnership interest in AVM. Consulier cannot, with any degree of assurance, predict whether there will be a continuation of the net return from our interest in AVM, Ltd., for the three months ended March 31, 2008, nor whether we will continue to be able to obtain additional funding when necessary. However, Consulier does not expect that the rate of return will decline to the point where Consulier has negative cash flow. Furthermore, although AVM has given Consulier no indication that it intends to redeem the Company’s interest in AVM, there can be no assurance that AVM will not do so in the future.
Consulier is planning to continue to invest in ST, LLC and estimates an additional investment of $5 million to $7 million during the next 5 years, at which time the goal is for ST, LLC to be at the break-even point for its operations. The Company anticipates that the cash which it will use to invest in ST, LLC, will be available from the Company’s interest AVM, LP and BioSafe, LLC.
The Company does not trade derivative instruments. However, AVM enters into various transactions involving derivatives and other off-balance sheet financial instruments. These derivatives and off-balance sheet instruments are subject to varying degrees of market and credit risk.

29


Table of Contents

OUTLOOK
Based on AVM’s operations over the past 5 years, management expects continued annualized return in 2008 on its interest in AVM; however, there is no guarantee that the annualized return in the first quarter of 2008 will be maintained throughout fiscal 2008.
Consulier International, Inc., continues to develop new retail and distribution outlets locally, nationally and internationally. However, sales of that company’s primary product, Captain Cra-Z Hand and All Purpose Cleaner, have decreased for the three months ended March 31, 2008, by 7% over the comparable 2007 period.
In the first quarter, Patient Care Technology Systems (PCTS) signed a strategic teaming partnership agreement with 3M Track and Trace Solutions, who will bring the PCTS portfolio of integrated workflow solutions to 3M’s customers. 3M, a broadly diversified technology company, is a leader in the emerging field of Track and Trace, which employs Radio Frequency Identification (RFID) in a variety of ways to identify and track high-value assets for a growing variety of healthcare applications. The 3M and PCTS teaming partnership spans both technology and go-to-market integration. PCTS signed a reseller agreement with AeroScout, Inc., a leading provider of Wi-Fi-based active RFID locating technologies. PCTS intends to resell this locating technology, which utilizes a hospital’s existing Wi-Fi network, as an integrated component of its departmental and enterprise-wide workflow automation solutions. The agreement broadens PCTS’ portfolio of leading real-time location technologies to which it can integrate its software. PCTS successfully implemented its perioperative department tracking software at the first of three facilities within the Lehigh Valley Hospital and Health Network, a nationally-recognized health care provider. An existing customer, MediCorp, signed a contract to install PCTS’ emergency department tracking and documentation software in a new hospital and a stand-alone clinic currently under construction. MediCorp’s flagship facility, Mary Washington Hospital, has been using the software since 2002. PCTS announced that over one million emergency department patient visits have now been electronically charted using its Amelior ED™ software. Executive representatives from three of PCTS’ customers spoke on their organizations’ success with their emergency and perioperative department workflow automation software at the annual HIMSS Conference in Orlando, the largest event within the health care information technology market.
PCTS currently supports 24 completed installations of its core product line of electronic tracking and documentation solutions with over 12 implementations in progress. Including its non-core solutions, PCTS supports a total customer base of 64 implementations representing over 1.7 million annual patient encounters.

30


Table of Contents

The Company’s loss from its interest in BioSafe Systems, LLC was $43,813 for the three months ended March 31, 2008, compared to income of $94,276 for the three months ended March 31, 2007. The agricultural market segment continues to be strong, with a sales increase of 4% over the comparable three month period in 2007. The home & garden market segment had a very difficult first quarter. This was caused by competitive pressures to reduce their sales prices offset by significant increases in material, production and shipping costs. BioSafe’s new products have been well received by the customers in this market segment and BioSafe is actively seeking new distributors to widen its customer base. With an increased sales and marketing effort and new national distribution channels, BioSafe expects its growth in this market to continue. In March 2008, BioSafe implemented a 5% price increase to offset cost increases.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The Company is a smaller reporting company, as defined in Rule 12b-2 promulgated under the Securities Exchange Act of 1934, and is accordingly not required to provide the information required by this Item.
ITEM 4T. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this report, or the “Evaluation Date,” we carried out an evaluation under the supervision and with the participation of our management, including our Chief Executive Office and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the “Exchange Act”). Because of its inherent limitations, our internal control over financial reporting may not prevent material errors or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. The continued effectiveness of our internal control over financial reporting is subject to risks, including that the controls may become inadequate because of changes in conditions or that the degree of compliance with our policies or procedures may deteriorate. Subject to the limitations, and based on the evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of the Evaluation Date, the disclosure controls are not effective as a result of the material weakness discussed in Item 8A, “Controls and Procedures, “of our Annual Report on Form 10-KSB for the year ended December 31, 2007.
We are in the process of implementing changes to respond to the aforementioned material weakness on an immediate and longer term basis. We have begun remediation and expect to continue to implement further improvements throughout the next three months.

31


Table of Contents

ITEM 4T. CONTROLS AND PROCEDURES (CONTINUED)
Changes in Internal Control over Financial Reporting
We are investing in ongoing efforts to continuously improve our internal control over financial reporting and have committed resources to the improvement of the design, implementation, documentation, testing and monitoring of our internal controls.
As of the date of this filing, we believe that we have made progress in the implementation of the corrective actions noted above and toward remediation of the material weakness disclosed in Item 8A, “Controls and Procedures,” of our Annual Report of Form 10-KSB for the fiscal year ended December 31, 2007.
Except for such corrective actions, there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended March 31, 2008 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

32


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
On August 2, 2006, PCTS was made a defendant to a lawsuit filed by Hill-Ron Services, Inc. et al. vs. Versus Technology, et al., United States District Court, Middle District of North Carolina, Civil Action No. 1:03CV01227, as a successor in interest to Healthcare Information Technology, Inc., and as a customer of a vendor concerning the vendor’s disputed patent ownership and unauthorized use of such patents. Effective January 21, 2008, all claims against PCTS were settled and the case was dismissed.
ITEM 1A. RISK FACTORS
The Company is a smaller reporting company, as defined in Rule 12b-2 promulgated under the Securities Exchange Act of 1934, and is accordingly not required to provide the information required by this Item.

33


Table of Contents

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
In April 2007, the Company adopted a plan to repurchase up to 50,000 shares of its common stock on the open market at a price not to exceed $3.75 per share plus brokerage fees. In January 2008, the Company adopted a second plan to repurchase up to an additional 50,000 shares of its common stock on the open market at a price not to exceed $3.50 plus brokerage fees. Since April, 2007 through March 31, 2008, the Company repurchased 81,667 shares of its common stock. The following table sets forth the information on the repurchases of stock during the quarter ended March 31, 2008.
Issuer Purchases of Equity Securities
                                             
 
                                      (d)  
                            (c)     Maximum number (or  
                            Total number of     approximate dollar  
                            shares (or units)     value) of shares  
        (a)               purchased as part     (or units) that may  
        Total number of     (b)     of publicly     yet be purchased  
        shares (or units)     Average price paid     announced plans or     under the plans or  
  Period     purchased     per share (or unit)     programs     programs  
 
Month #1 January 1-31, 2008
      3,675         3.80         3,675       None  
 
Month #2 February 1-29, 2008
      29,899         3.55         29,899       20,101 Shares  
 
Month #3 March 1-31, 2008
      1,762         3.55         1,762       18,339 Shares  
 
Total
      35,336                   35,336              
 

34


Table of Contents

CONSULIER ENGINEERING, INC. AND SUBSIDIARIES
PART II. OTHER INFORMATION (CONTINUED)
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None.
ITEM 5. OTHER INFORMATION
None.
ITEM 6. EXHIBITS
  (a)   EXHIBITS REQUIRED BY ITEM 601 OF REGULATION S-B
 
      None
 
  (b)   CURRENT REPORTS ON FORM 8-K
 
      None
 
  (c)   31.1 — Certification of Chief Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002
 
  (d)   31.2 — Certification of Chief Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002
 
  (e)   32.1 — Certification of Chief Executive Officer Pursuant to Section 906 of Sarbanes-Oxley Act of 2002
 
  (f)   32.2 — Certification of Chief Financial Officer Pursuant to Section 906 of Sarbanes-Oxley Act of 2002
 
      The Company has attached Exhibits 31.1, 31.2, 32.1 and 32.2 to this filing to comply with the requirements of the Sarbanes-Oxley Act of 2002.

35


Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
         
  CONSULIER ENGINEERING, INC.
(Registrant)
 
 
Date: May 20, 2008  By:   /s/ Alan R Simon    
    Alan R. Simon, Esq.   
    Secretary and Treasurer (Principal
Financial and Accounting Officer) 
 
 
     
Date: May 20, 2008  By:   /s/ Warren B. Mosler    
    Warren B. Mosler    
    Chairman of the Board, President
& Chief Executive Officer (Principal Executive Officer) 
 

36